BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2155315)

  • 1. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.
    Alavi A; Kramer E; Wegener W; Alavi J
    J Nucl Med; 1990 Mar; 31(3):360-4. PubMed ID: 2155315
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
    Bolo NR; Brennan KM; Jones RM; Budinger TF
    Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Localized imaging with 18F-fluorodeoxyglucose].
    Paul R; Ahonen A
    Duodecim; 1985; 101(12):1167-77. PubMed ID: 3874764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tomographic mapping of rate constants of [F-18] FDG model].
    Sasaki H; Kanno I; Miura S; Murakami M; Takahashi K; Shishido F; Uemura K
    Kaku Igaku; 1985 Jan; 22(1):81-4. PubMed ID: 3873558
    [No Abstract]   [Full Text] [Related]  

  • 5. Ringlike uptake of [18F]FDG in brain abscess: a PET study.
    Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K
    J Comput Assist Tomogr; 1990; 14(3):486-7. PubMed ID: 2335626
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of fluorodeoxyglucose-positron emission tomography in the evaluation of seizure disorders.
    Theodore WH
    Semin Neurol; 1989 Dec; 9(4):301-6. PubMed ID: 2518339
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
    Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
    J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional brain imaging in 200 patients after whiplash injury.
    Otte A; Mueller-Brand J; Nitzsche EU; Wachter K; Ettlin TM
    J Nucl Med; 1997 Jun; 38(6):1002. PubMed ID: 9189162
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study for tumor detection using 18F-2-fluoro-deoxy-D-glucose: imaging of rabbit VX2-tumor with single photon gamma camera].
    Abe Y; Matsuzawa T; Fukuda H; Endo S; Yamada K; Sato T; Ito M; Kubota K; Hatazawa J; Yoshioka S
    Kaku Igaku; 1985 Mar; 22(3):389-91. PubMed ID: 3874982
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
    Alavi A; Smith R; Duncan D
    J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
    [No Abstract]   [Full Text] [Related]  

  • 11. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
    Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
    Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
    Di Chiro G
    Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased fluorine-18 deoxyglucose uptake after percutaneous transluminal coronary angioplasty in recently infarcted myocardium.
    Hashimoto T; Kambara H; Fudo T; Nohara R; Hayashi M; Takatsu Y; Tamaki N; Konishi J; Kawai C
    Am J Cardiol; 1989 Mar; 63(11):743-4. PubMed ID: 2522272
    [No Abstract]   [Full Text] [Related]  

  • 15. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 16. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
    Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T
    Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
    Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
    Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
    [No Abstract]   [Full Text] [Related]  

  • 18. Clarification of a fractional uptake concept.
    Thie JA
    J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results.
    Reivich M; Alavi A; Greenberg J; Farkas T; Wolf A
    Prog Nucl Med; 1981; 7():138-48. PubMed ID: 7323304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.